Tata India Pharma & Healthcare Fund - Direct - Growth
A Equity Scheme by Tata Asset Management Limited
3Y Returns (CAGR)
22.95%
Expense Ratio
0.69%
as of 01/03/2026
AUM
₹402.95 Cr
Qtr End: Dec 25
NAV
₹34.578
as of 17/04/2026
3Y Returns (CAGR)
22.95%
Expense Ratio
0.69%
as of 01/03/2026
AUM
₹402.95 Cr
Qtr End: Dec 25
NAV
₹34.578
as of 17/04/2026
Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
| Period | Returns | CAGR | Volatility |
|---|---|---|---|
| 3M | -0.08% | -0.33% | 15.31% |
| 6M | -4.72% | -9.23% | 12.56% |
| 1Y | 0.71% | 0.71% | 11.70% |
| 3Y | 85.86% | 22.95% | 13.30% |
| 5Y | 93.98% | 14.17% | 13.13% |
Scheme Details
- Launch Date
- 04/12/2015
- Fund Age
- 10.4 years
- Minimum Investment
- ₹5,000
- Fund House
- Tata Mutual Fund
- Category
- Equity Scheme
- Sub-category
- Sectoral/ Thematic (Equity Scheme)
Similar Funds
Top funds in the same category and sub-category.
| Scheme | 3Y CAGR (%) | TER (%) | AUM (Cr) |
|---|---|---|---|
| Aditya Birla Sun Life International Equity Fund - Direct - Growth | 19.01% | 2.06% | ₹69.63 |
| DSP Banking & Financial Services Fund - Direct - Growth | - | 0.61% | ₹280.2 |
| SBI BANKING & FINANCIAL SERVICES FUND - Direct - Growth | 19.65% | 0.88% | ₹4,503.48 |
| HDFC Defence Fund - Direct - Growth | - | 0.82% | ₹1,912.49 |
| Mirae Asset Banking and Financial Services Fund - Direct - Growth | 17.17% | 0.63% | ₹344.25 |
| ITI Banking and Financial Services Fund - Direct - Growth | 14.54% | 0.40% | ₹10.21 |
| Tata Banking & Financial Services Fund - Direct - Growth | 16.42% | 0.51% | ₹899.75 |